More on TGTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $55.98 |
|
|||
| Open | $55.99 | ||||
| 52 Wk High | $14.87 | ||||
| 52 Wk Low | $4.90 | ||||
| Day High | $55.99 | ||||
| Day Low | $55.99 | ||||
| P/E | N/A | ||||
| EPS | $-0.67 | ||||
| Volume | 11,549 | ||||
- Form 4 TG THERAPEUTICS, INC. For: Aug 06 Filed by: Charney Laurence N
- TG Therapeutics (TGTX) PT Raised to $72 at JPMorgan
- Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
- Form 10-Q TG THERAPEUTICS, INC. For: Jun 30
- TG Therapeutics (TGTX) PT Raised to $78 at H.C. Wainwright
- Form 8-K TG THERAPEUTICS, INC. For: Aug 03
- TG Therapeutics raises 2026 revenue guidance on Briumvi sales growth
- TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance
- Buy this biotech stock into Q2 earnings: Analyst
- TG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update
Entities mentioned with TGTX
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- AdCom | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
